PetMed Express, Inc. Sets Fiscal First Quarter 2025 Earnings Call
PetMed Express, Inc. (Nasdaq: PETS), operating as PetMeds and parent company of PetCareRx, has announced its upcoming fiscal first quarter 2025 earnings call. The conference call is scheduled for Tuesday, August 6, 2024, at 4:30pm Eastern time. PETS management will host the call, which will be followed by a question-and-answer session.
Financial results for the quarter ended June 30, 2024, will be released via press release prior to the call. Investors can access the call using the U.S. dial-in number 844-826-3035 or the international number 412-317-5195. A webcast will also be available. For those unable to attend, a telephonic replay will be accessible until August 20, 2024.
PetMed Express, Inc. (Nasdaq: PETS), operante come PetMeds e società madre di PetCareRx, ha annunciato la prossima call sugli utili per il primo trimestre fiscale del 2025. La conferenza telefonica è programmata per martedì 6 agosto 2024, alle 16:30 ora orientale. La direzione di PETS condurrà la call, che sarà seguita da una sessione di domande e risposte.
I risultati finanziari per il trimestre terminato il 30 giugno 2024, saranno resi noti tramite comunicato stampa prima della call. Gli investitori possono accedere alla call utilizzando il numero di accesso degli Stati Uniti 844-826-3035 o il numero internazionale 412-317-5195. Sarà inoltre disponibile una diretta web. Per coloro che non possono partecipare, ci sarà una registrazione telefonica accessibile fino al 20 agosto 2024.
PetMed Express, Inc. (Nasdaq: PETS), que opera como PetMeds y es la empresa matriz de PetCareRx, ha anunciado su próxima llamada sobre resultados financieros del primer trimestre fiscal de 2025. La conferencia está programada para martes 6 de agosto de 2024, a las 4:30 p.m. hora del este. La dirección de PETS será la encargada de conducir la llamada, que será seguida de una sesión de preguntas y respuestas.
Los resultados financieros para el trimestre finalizado el 30 de junio de 2024 se publicarán a través de un comunicado de prensa antes de la llamada. Los inversores pueden acceder a la llamada usando el número de EE.UU. 844-826-3035 o el número internacional 412-317-5195. También habrá una transmisión web disponible. Para aquellos que no puedan asistir, habrá una repetición telefónica accesible hasta el 20 de agosto de 2024.
PetMed Express, Inc. (Nasdaq: PETS), PetMeds로 운영되며 PetCareRx의 모회사인 PetMed Express가 2025 회계연도 첫 분기 실적 발표 전화를 예정하고 있음을 발표했습니다. 컨퍼런스 콜은 2024년 8월 6일 화요일 오후 4시 30분 동부 기준으로 잡혀 있습니다. PETS 경영진이 전화를 주최하며, 이후 질문과 답변 세션이 이어질 예정입니다.
2024년 6월 30일에 종료된 분기의 재무 결과는 콜 전에 보도 자료를 통해 발표됩니다. 투자자들은 미국 전화번호 844-826-3035 또는 국제 전화번호 412-317-5195를 사용하여 콜에 접근할 수 있습니다. 웹캐스트도 제공될 예정입니다. 참석할 수 없는 분들을 위해서는 2024년 8월 20일까지 접근 가능한 전화 재송신 서비스가 제공됩니다.
PetMed Express, Inc. (Nasdaq: PETS), opérant sous le nom de PetMeds et société mère de PetCareRx, a annoncé son prochain appel sur les résultats pour le premier trimestre fiscal 2025. La conférence téléphonique est prévue pour mardi 6 août 2024, à 16h30 heure de l'Est. La direction de PETS animera l'appel, qui sera suivi d'une session de questions et réponses.
Les résultats financiers pour le trimestre clos le 30 juin 2024 seront publiés par communiqué de presse avant l'appel. Les investisseurs peuvent accéder à l'appel en utilisant le numéro d'appel américain 844-826-3035 ou le numéro international 412-317-5195. Un webinaire sera également disponible. Pour ceux qui ne peuvent pas participer, une rediffusion téléphonique sera accessible jusqu'au 20 août 2024.
PetMed Express, Inc. (Nasdaq: PETS), das als PetMeds auftritt und das Mutterunternehmen von PetCareRx ist, hat seinen bevorstehenden Gewinnaufruf für das erste Quartal des Geschäftsjahres 2025 angekündigt. Die Telefonkonferenz ist für Dienstag, den 6. August 2024, um 16:30 Uhr Ostküstenzeit angesetzt. Das Management von PETS wird die Konferenz leiten, gefolgt von einer Frage-und-Antwort-Runde.
Die finanziellen Ergebnisse für das am 30. Juni 2024 endende Quartal werden vor der Konferenz mittels Pressemitteilung veröffentlicht. Investoren können an dem Anruf unter der US-Nummer 844-826-3035 oder der internationalen Nummer 412-317-5195 teilnehmen. Es wird auch eine Webcast verfügbar sein. Für diejenigen, die nicht teilnehmen können, wird eine telefonische Wiederholung bis zum 20. August 2024 zugänglich sein.
- None.
- None.
DELRAY BEACH, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, August 6, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call.
PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time.
Date: Tuesday, August 6, 2024
Time: 4:30pm Eastern time (1:30pm Pacific time)
U.S. dial-in number: 844-826-3035
International number: 412-317-5195
Webcast: 1Q Earnings Webcast
A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through August 20, 2024.
Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 10190753
About PetMed Express, Inc.
Founded in 1996, PetMeds is a leader in the digital pet pharmacy industry. As a national online retailer, PetMeds.com and PetCareRx.com are top choices for delivering preventive and chronic symptom prescriptions and OTC medications and products through their thousands of veterinary partners and a loyal customer base. Leveraging telehealth and insurance partnerships, they offer unparalleled value and convenience to pet parents at every stage of their pets' lives, whether dogs, cats, or horses. PetMeds and PetCareRx provide a comprehensive range of medications, food products, and essential supplies through their websites, www.PetMeds.com and www.PetCareRx.com.
Investor Contact:
ICR, LLC
John Mills
(646) 277-1254
Reed Anderson
(646) 277-1260
FAQ
When is PetMed Express (PETS) releasing its fiscal Q1 2025 earnings?
How can investors participate in PetMed Express's (PETS) Q1 2025 earnings call?
What period does PetMed Express's (PETS) fiscal Q1 2025 earnings report cover?
Will there be a replay available for PetMed Express's (PETS) Q1 2025 earnings call?
